# The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

> **NCT01148004** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 25 (actual)

## Conditions studied

- HIV
- Fenofibrate
- Protease Inhibitors
- Hypertriglyceridemia
- Glucuronosyltransferase

## Interventions

- **DRUG:** Fenofibrate
- **DRUG:** Ritonavir
- **DRUG:** Lopinavir/Ritonavir

## Key facts

- **NCT ID:** NCT01148004
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-13
- **Primary completion:** 2013-07-29
- **Final completion:** 2013-07-29
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148004, "The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT01148004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*